Cargando…

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model

BACKGROUND: Each year rotavirus gastroenteritis results in thousands of paediatric hospitalisations and primary care visits in the Netherlands. While two vaccines against rotavirus are registered, routine immunisation of infants has not yet been implemented. Existing cost-effectiveness studies showe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rozenbaum, Mark H, Mangen, Marie-Josee J, Giaquinto, Carlo, Wilschut, Jan C, Hak, Eelko, Postma, Maarten J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129591/ https://www.ncbi.nlm.nih.gov/pubmed/21663620 http://dx.doi.org/10.1186/1471-2458-11-462

Ejemplares similares

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
por: Tu, Hong Anh T, et al.
Publicado: (2013)

Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost
por: Zeevat, Florian, et al.
Publicado: (2021)

803 Direct Costs and Duration of Hospitalization of Patients Hospitalized with Community Acquired Pneumonia: a Nationwide Retrospective Claims Database Analysis
por: Rozenbaum, Mark, et al.
Publicado: (2014)

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
por: Mangen, Marie-Josée J., et al.
Publicado: (2015)

Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines
por: Wondimu, Abrham, et al.
Publicado: (2019)

Contributing factors to influenza vaccine uptake in general hospitals: an explorative management questionnaire study from the Netherlands
por: Riphagen-Dalhuisen, Josien, et al.
Publicado: (2012)

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
por: Postma, Maarten J, et al.
Publicado: (2011)

Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination
por: Bruijning-Verhagen, Patricia, et al.
Publicado: (2013)

Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents
por: Gefenaite, Giedre, et al.
Publicado: (2012)

Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccination
por: Assink, M.D.M., et al.
Publicado: (2009)

Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation
por: Suijkerbuijk, Anita WM, et al.
Publicado: (2020)

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
por: de Boer, Pieter T., et al.
Publicado: (2018)

The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands
por: Al Khayat, Mohamed N.M.T., et al.
Publicado: (2020)

An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands
por: Luttjeboer, Jos, et al.
Publicado: (2023)

The potential economic value of influenza vaccination for healthcare workers in The Netherlands
por: Meijboom, Marjan J., et al.
Publicado: (2018)

Is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, The Netherlands, Cost-Effective?
por: Urbanus, Anouk T., et al.
Publicado: (2013)

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands
por: Eijsink, Job F. H., et al.
Publicado: (2020)

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
por: Thorrington, Dominic, et al.
Publicado: (2018)

Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial
por: van Werkhoven, Cornelis H., et al.
Publicado: (2017)

Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia
por: Suwantika, Auliya A, et al.
Publicado: (2013)

1439. The Cost-Effectiveness of Vaccinating Adults at Increased Risk of Pneumococcal Disease Against Pneumococcal Disease in The Netherlands
por: Rozenbaum, Mark
Publicado: (2018)

Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
por: Simons, Joost J.M., et al.
Publicado: (2022)

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
por: Westra, Tjalke A, et al.
Publicado: (2013)

1434. Cost-Effectiveness of Sequencial Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23 Valent Polysaccharide Vaccine (PPV23) in The Netherlands
por: Rozenbaum, Mark
Publicado: (2018)

Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination
por: Gefenaite, Giedre, et al.
Publicado: (2013)

Accounting for long-term manifestations of Cryptosporidium spp infection in burden of disease and cost-of-illness estimations, the Netherlands (2013–2017)
por: Monge, Susana, et al.
Publicado: (2019)

Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
por: Stevanović, Jelena, et al.
Publicado: (2014)

Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
por: van der Schans, Jurjen, et al.
Publicado: (2015)

Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study
por: Marbus, Sierk D., et al.
Publicado: (2020)

Inequalities in Rotavirus Vaccine Uptake in Ethiopia: A Decomposition Analysis
por: Wondimu, Abrham, et al.
Publicado: (2020)

Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model
por: de Vries, Robin, et al.
Publicado: (2010)

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2019)

Cost-effectiveness of Rotavirus vaccination in Vietnam
por: Kim, Sun-Young, et al.
Publicado: (2009)

Meningococcal Serogroup A, C, W(135) and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands
por: Hepkema, Hiltsje, et al.
Publicado: (2013)

Economic Assessment of High-Dose Versus Adjuvanted Influenza Vaccine: An Evaluation of Hospitalization Costs Based on a Cohort Study
por: van Aalst, Robertus, et al.
Publicado: (2021)

Effects of an ageing population and the replacement of immune birth cohorts on the burden of hepatitis A in the Netherlands
por: McDonald, Scott A, et al.
Publicado: (2013)

Cost-effectiveness of rotavirus vaccination in Mozambique
por: Lourenço Guimarães, Esperança, et al.
Publicado: (2022)

Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data
por: Standaert, Baudouin, et al.
Publicado: (2013)

Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC)
por: de Hoog, Marieke L. A., et al.
Publicado: (2018)

Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005–2015
por: Pradipta, Ivan S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4l0oj6a7i4apmr7seqeavu2cku